Single-Manager Hedge Funds: The Best Way to Get a Recurring Guest Spot on CNBC?
Mergers and Inquisitions
JANUARY 31, 2024
In-depth analysis that might take days or weeks, such as a financial model with 1,000 rows in Excel to assess a biopharma company’s valuation. This is especially common in areas like distressed debt investing that depend heavily on catalysts. Speaking with customers, suppliers, management teams, and market participants.
Let's personalize your content